| Literature DB >> 29214000 |
Roholla Taghadosi1, Mohammad Reza Shakibaie1, Reza Ghanbarpour2, Hossein Hosseini-Nave1.
Abstract
BACKGROUND AND OBJECTIVES: The objectives of this study were to evaluate the antibiotic resistance profiles, biofilm formation, presence of antigen 43 (Ag43) gene, and transfer of antibiotic resistance phenotype among non-O157 Shiga toxin producing Escherichia coli (STEC).Entities:
Keywords: Antibiotic resistance; Biofilm; Conjugation; PCR; Shiga toxin producing E. coli
Year: 2017 PMID: 29214000 PMCID: PMC5715282
Source DB: PubMed Journal: Iran J Microbiol ISSN: 2008-3289
Fig. 1.Antibiotic resistant profile of non-O157 STEC isolates in fecal samples of calves, goats and humans origins.
Abbreviations: AK= amikacin, AP= ampicillin, ATM= aztreonam, AUG= amoxicillin/clavulanic acid, CAZ= ceftazidime, CIP= ciprofloxacin, CRO= ceftriaxone, CXM= cefotaxime, IMI= imipenem, K= kanamycin, NA= nalidixic acid, PRL= piperacillin, TN= tobramycin, TS= trimethoprim/sulfa methoxazole. Antibiotic resistance was performed at CFU 1 × 108 inoculum size in Muller-Hinton agar.
Fig. 2.Agarose gel electrophoresis of PCR product of amplified antigen 43 autoadhesin gene detected in non-O157 STEC isolates from animal and human origins. Lanes 1 to 14 indicates strain numbers. DNA marker was consisting of a ladder with 100bp. Electrophoresis was conducted in 1.5 % agarose gel.
Fig. 3.Biofilm quantification, and presence of Ag43 in non-O157 STEC strains isolated from stools of healthy calves, goats and patients with mild diarrhea. P. aeruginosa PAO1 was used as positive control.
Horizontal transfer of antibiotic resistance between cefotaxime resistance strains of non-O157 STEC as donor and E. coli ATCC25922.1 (Nalr) as recipient.
| STEC 1050 | Nal (100 μg/ml) + CXM (25 μg/ml) | 1.6 ×10−4 | |
| STEC1152 | Nal (100 μg/ml) + CXM (25 μg/ml) | – |
Nal= nalidixic acid, CXM= cefotaxime. Conjugation frequency calculated as number transconjugants colonies divided by recipient colonies multiply dilution factor. Simultaneously, controls for both donor and recipient were carried out to check the presence of spontaneously developed mutants.